BiomX Statistics
Total Valuation
BiomX has a market cap or net worth of $11.52 million. The enterprise value is $693,577.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BiomX has 26.18 million shares outstanding. The number of shares has increased by 175.81% in one year.
| Current Share Class | 26.18M |
| Shares Outstanding | 26.18M |
| Shares Change (YoY) | +175.81% |
| Shares Change (QoQ) | +26.63% |
| Owned by Insiders (%) | 5.57% |
| Owned by Institutions (%) | 26.11% |
| Float | 16.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.00 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.38.
| Current Ratio | 3.35 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.02% and return on invested capital (ROIC) is -69.74%.
| Return on Equity (ROE) | -34.02% |
| Return on Assets (ROA) | -36.60% |
| Return on Invested Capital (ROIC) | -69.74% |
| Return on Capital Employed (ROCE) | -96.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$141,386 |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BiomX has paid $9,000 in taxes.
| Income Tax | 9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.06% in the last 52 weeks. The beta is 1.44, so BiomX's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -87.06% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 42.90 |
| Average Volume (20 Days) | 278,475 |
Short Selling Information
The latest short interest is 236,325, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 236,325 |
| Short Previous Month | 72,186 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 1.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.26M |
| Pretax Income | -37.11M |
| Net Income | -8.06M |
| EBITDA | -35.45M |
| EBIT | -37.26M |
| Earnings Per Share (EPS) | -$2.13 |
Full Income StatementBalance Sheet
The company has $20.12 million in cash and $9.29 million in debt, giving a net cash position of $10.82 million or $0.41 per share.
| Cash & Cash Equivalents | 20.12M |
| Total Debt | 9.29M |
| Net Cash | 10.82M |
| Net Cash Per Share | $0.41 |
| Equity (Book Value) | 24.50M |
| Book Value Per Share | 0.23 |
| Working Capital | 16.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.34 million and capital expenditures -$30,000, giving a free cash flow of -$34.37 million.
| Operating Cash Flow | -34.34M |
| Capital Expenditures | -30,000 |
| Free Cash Flow | -34.37M |
| FCF Per Share | -$1.31 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BiomX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -175.81% |
| Shareholder Yield | -175.81% |
| Earnings Yield | -69.97% |
| FCF Yield | -298.37% |
Analyst Forecast
The average price target for BiomX is $15.00, which is 3,309.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 3,309.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -7.19% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Aug 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |